Delivra Health Brands Inc. DHBUF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 38.46% | -47.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 38.46% | -47.91% | |||
| Cost of Revenue | 26.12% | -34.90% | |||
| Gross Profit | 75.61% | -67.48% | |||
| SG&A Expenses | -10.89% | -7.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.67% | -21.57% | |||
| Operating Income | 38.38% | -120.85% | |||
| Income Before Tax | 30.20% | -154.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.20% | -154.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.20% | -154.21% | |||
| EBIT | 38.38% | -120.85% | |||
| EBITDA | 38.38% | -120.85% | |||
| EPS Basic | 30.42% | -155.32% | |||
| Normalized Basic EPS | 35.29% | -104.00% | |||
| EPS Diluted | 30.42% | -155.32% | |||
| Normalized Diluted EPS | 35.29% | -104.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||